Our findings therefore have important therapeutic implications and strategies to block IL-1R8 activity directly or through combined therapies as a way to restore innate immune system activation and T cell trafficking in breast cancer TME should be further explored. The gene discussed is SIGIRR; the disease is breast carcinoma.